Enforcement record
Business Suspension Order disclosure naming 株式会社メディファーマ
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Business Suspension Order
Law
医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律
Authority
Ministry of Health, Labour and Welfare
Action date
17 October 2023
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
- Captured: Jul 12, 2026, 03:34 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Public documents and saved materials
View the original publications, see what was preserved, or download each file below.
Loading materials…
Action summary
- Company
- 株式会社メディファーマJapanese onlyOriginal: 株式会社メディファーマ
- Governing law
- 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律
- Action type
- Business Suspension Order業務停止命令
- Action date
- 17 October 2023
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品・医療機器臨床試験
Violation
Falsification of clinical trial data, improper conduct of respiratory function tests, sharing of ID passwords among doctors, facility staff, and CRCs, proxy attendance at training sessions, and concealment of storage deficiencies of the investigational drug.
Show original Japanese text
治験データの改竄、呼吸機能検査の不適切な実施、医師・施設スタッフ・CRCのIDパスワード共有、トレーニング代理受講、治験薬保管不備の隠蔽
Compliance context
HighA formal order requiring suspension of business activities for the covered scope or period.
Japanese regulatory disclosure under 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律.
Escalate for legal or third-party risk review before onboarding or continuing a material relationship.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.